These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25003192)

  • 1. Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα.
    Lu Y; Liu X; Jiao Y; Xiong X; Wang E; Wang X; Zhang Z; Zhang H; Pan L; Guan Y; Cai D; Ning G; Li X
    J Clin Invest; 2014 Aug; 124(8):3501-13. PubMed ID: 25003192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periostin: a new extracellular regulator of obesity-induced hepatosteatosis.
    Wu T; Wu S; Ouyang G
    Cell Metab; 2014 Oct; 20(4):562-4. PubMed ID: 25295785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
    Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J
    PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
    Barroso E; Rodríguez-Calvo R; Serrano-Marco L; Astudillo AM; Balsinde J; Palomer X; Vázquez-Carrera M
    Endocrinology; 2011 May; 152(5):1848-59. PubMed ID: 21363937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.
    Azar S; Udi S; Drori A; Hadar R; Nemirovski A; Vemuri KV; Miller M; Sherill-Rofe D; Arad Y; Gur-Wahnon D; Li X; Makriyannis A; Ben-Zvi D; Tabach Y; Ben-Dov IZ; Tam J
    Mol Metab; 2020 Dec; 42():101087. PubMed ID: 32987186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant miR199a-5p/caveolin1/PPARα axis in hepatic steatosis.
    Li B; Zhang Z; Zhang H; Quan K; Lu Y; Cai D; Ning G
    J Mol Endocrinol; 2014 Dec; 53(3):393-403. PubMed ID: 25312970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocyte-derived Periostin mediates glucocorticoid-induced hepatosteatosis in mice.
    Wan J; Shan Y; Song X; Chen S; Lu X; Jin J; Su Q; Liu B; Sun W; Li B
    Mol Metab; 2020 Jan; 31():24-35. PubMed ID: 31918919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.
    Komatsu M; Kimura T; Yazaki M; Tanaka N; Yang Y; Nakajima T; Horiuchi A; Fang ZZ; Joshita S; Matsumoto A; Umemura T; Tanaka E; Gonzalez FJ; Ikeda S; Aoyama T
    Biochim Biophys Acta; 2015 Mar; 1852(3):473-81. PubMed ID: 25533124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non-alcoholic steatohepatitis.
    Kobayashi T; Kanno K; Nguyen PT; Sugiyama A; Kawahara A; Otani Y; Kishikawa N; Ito M; Tazuma S
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2140-2150. PubMed ID: 32365405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity.
    Stec DE; Gordon DM; Hipp JA; Hong S; Mitchell ZL; Franco NR; Robison JW; Anderson CD; Stec DF; Hinds TD
    Am J Physiol Regul Integr Comp Physiol; 2019 Nov; 317(5):R733-R745. PubMed ID: 31483154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-specific deletion of IGF2 mRNA binding protein-2/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation.
    Regué L; Minichiello L; Avruch J; Dai N
    J Biol Chem; 2019 Aug; 294(31):11944-11951. PubMed ID: 31209109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.
    Huang J; Jia Y; Fu T; Viswakarma N; Bai L; Rao MS; Zhu Y; Borensztajn J; Reddy JK
    FASEB J; 2012 Feb; 26(2):628-38. PubMed ID: 22009939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The herbal composition GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits high-fat diet-induced hepatic steatosis via hepatic PPARα activation.
    Shin SS; Yoon M
    Pharm Biol; 2012 Oct; 50(10):1261-8. PubMed ID: 22870903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia.
    Kulozik P; Jones A; Mattijssen F; Rose AJ; Reimann A; Strzoda D; Kleinsorg S; Raupp C; Kleinschmidt J; Müller-Decker K; Wahli W; Sticht C; Gretz N; von Loeffelholz C; Stockmann M; Pfeiffer A; Stöhr S; Dallinga-Thie GM; Nawroth PP; Diaz MB; Herzig S
    Cell Metab; 2011 Apr; 13(4):389-400. PubMed ID: 21459324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia via ERK Signaling Inhibits Hepatic PPARα to Promote Fatty Liver.
    Mooli RGR; Rodriguez J; Takahashi S; Solanki S; Gonzalez FJ; Ramakrishnan SK; Shah YM
    Cell Mol Gastroenterol Hepatol; 2021; 12(2):585-597. PubMed ID: 33798787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fish oil and fenofibrate prevented phosphorylation-dependent hepatic sortilin 1 degradation in Western diet-fed mice.
    Li J; Bi L; Hulke M; Li T
    J Biol Chem; 2014 Aug; 289(32):22437-49. PubMed ID: 24986865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition.
    Ramakrishnan SK; Khuder SS; Al-Share QY; Russo L; Abdallah SL; Patel PR; Heinrich G; Muturi HT; Mopidevi BR; Oyarce AM; Shah YM; Sanchez ER; Najjar SM
    J Biol Chem; 2016 Apr; 291(15):8121-9. PubMed ID: 26846848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha.
    Li G; Brocker CN; Yan T; Xie C; Krausz KW; Xiang R; Gonzalez FJ
    Mol Metab; 2018 Jan; 7():80-89. PubMed ID: 29146411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.